Bioequivalent Products

In conformity with DYNAPHARM's policy of always maintaining optimum safety and efficacy standards, the company consistently sends its selected products for Bioequivalent Studies as required by the Malaysian Ministry of Health.

Such studies conducted by an accredited Research Centre, serves to compare the Generic Products under study with the Proprietary Product. Dynapharm has so far sent 7 products for study, all of which passed the requirements of the tests and were certified acceptable. The 7 products as shown below:


Product Name Compare with Contents Dosage Forms Summary
Study Report
DYNORMIN TENORMIN
from Astrazeneca
Atenolol Tablet Download PDF
DYNAMET TAGAMET
from Glaxosmithkline
Cimetidine Tablet Download PDF
METFORMIN GLUCOPHAGE
from Lipha/ Merck
Metformin Tablet Download PDF
DYANIL DAONIL
from Aventis Farma
Glibenclamide Tablet Download PDF
CIPROFLOXACIN CIPROBAY
from Bayer
Ciprofloxacin Capsule Download PDF
KETOCONAZOLE NIZORAL
from Janssen-Cilag
Ketoconazole Tablet Download PDF
TICLOPIDINE Ticlid®
from Sanofi-Adventis
Ticlopidine Tablet Download PDF